216 related articles for article (PubMed ID: 10270788)
1. A cost containment checklist.
Garcia LS
MLO Med Lab Obs; 1985 Apr; 17(4):67-8, 71-5. PubMed ID: 10270788
[No Abstract] [Full Text] [Related]
2. Cutting laboratory costs: where we are most likely to succeed.
Bernstein LH; Sachs E
Pathologist; 1984 Dec; 38(12):795-8. PubMed ID: 10269204
[No Abstract] [Full Text] [Related]
3. Instituting change to cut lab costs.
Pelton TN
Pathologist; 1985 Jul; 39(7):17-20. PubMed ID: 10272022
[TBL] [Abstract][Full Text] [Related]
4. Hospitals for radical new cost rules.
MLO Med Lab Obs; 1983 Jan; 15(1):27-8. PubMed ID: 10298828
[No Abstract] [Full Text] [Related]
5. Medical audit. Putting pathology under the savings spotlight.
Kerr C
Health Soc Serv J; 1985 Dec; 95(4978):1576. PubMed ID: 10317686
[No Abstract] [Full Text] [Related]
6. Meeting the challenge of cost containment.
Miller J
Respir Ther; 1982; 12(5):78G-78H, 81-2. PubMed ID: 10259257
[No Abstract] [Full Text] [Related]
7. Cost containment in the clinical laboratory--to be or to seem to be, or when is a nontest a test?
Lundberg GD; Westlake GE
JAMA; 1980 Apr; 243(16):1659. PubMed ID: 7359758
[No Abstract] [Full Text] [Related]
8. Calling it like it is: reimbursement narcosis.
Schoen I
Pathologist; 1984 Nov; 38(11):747-8. PubMed ID: 10273593
[No Abstract] [Full Text] [Related]
9. Is that new instrument a winner?
Stafford AC
MLO Med Lab Obs; 1986 Apr; 18(4):24-8. PubMed ID: 10317714
[No Abstract] [Full Text] [Related]
10. Pathology practice under TEFRA and DRGs.
Breckenridge RL
Pathologist; 1983 Aug; 37(8):560-2. PubMed ID: 10310298
[TBL] [Abstract][Full Text] [Related]
11. Directing the post-TEFRA laboratory.
Sharp JW
Pathologist; 1985 Feb; 39(2):15-8. PubMed ID: 10270443
[TBL] [Abstract][Full Text] [Related]
12. Pathologists hope HHS clarification will give them leverage with hospitals.
Wallace C
Mod Healthc; 1984 Jun; 14(8):28, 30. PubMed ID: 10273518
[No Abstract] [Full Text] [Related]
13. Dr. Derman testifies on MD-DRGs.
Derman H
Pathologist; 1986 Aug; 40(8):51-4. PubMed ID: 10311691
[No Abstract] [Full Text] [Related]
14. What the new Medicare rules mean to pathologists.
Cole GW
MLO Med Lab Obs; 1983 May; 15(5):50-4. PubMed ID: 10299168
[No Abstract] [Full Text] [Related]
15. The retainer fee contract.
Schoen I
Pathologist; 1981 Aug; 35(8):438-9. PubMed ID: 10252492
[No Abstract] [Full Text] [Related]
16. The prognosis for the hospital-based pathologist--Part 1.
Bierig JR
Pathologist; 1986 Jul; 40(7):30-3. PubMed ID: 10277744
[TBL] [Abstract][Full Text] [Related]
17. Generating revenue through laboratory testing.
Hannon F
Hosp Entrep Newsl; 1987 Jun; 3(1):1-2, 8. PubMed ID: 10325197
[No Abstract] [Full Text] [Related]
18. How much does an MT program cost the hospital?
Wiebe MF
MLO Med Lab Obs; 1984 Mar; 16(3):105-8, 111. PubMed ID: 10310463
[No Abstract] [Full Text] [Related]
19. Decision making in pathology: what is the impact of economic and technologic change?
Davis GL
Pathologist; 1985 Apr; 39(4):23-7. PubMed ID: 10317590
[TBL] [Abstract][Full Text] [Related]
20. Lab salaries and benefits. Part I: Are they keeping pace?
Benezra N
MLO Med Lab Obs; 1987 Jan; 19(1):30-4. PubMed ID: 10280450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
